Decagon Asset Management »

Cidara Therapeutics shares owned by Decagon Asset Management

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Decagon Asset Management from 13F filings

Historical chart of Decagon Asset Management investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Decagon Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Decagon Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $22M 100k 220.89

More positions owned by Decagon Asset Management

Hologic (HOLX)
EXACT Sciences Corporation (EXAS)
Norfolk Southern (NSC)
Cidara Therapeutics Com New Call Option (CDTX)
Cyberark Software SHS (CYBR)
Avidity Biosciences Ord (RNA)
Yorkville Acquisition Corp. Shs Cl A (MCGA)
Inflection Point Acquisition Shs Cl A (BACQ)
Masterbrand Common Stock (MBC)
New Amer Acquisition I Corp Unit 99/99/9999 (NWAX.U)
Oaktree Acquisition Corp Iii Shs Cl A (OACC)
Crane Hbr Acquisition Corp Cl A (CHAC)
Mountain Lake Acquisition Shs Cl A (MLAC)
Bain Cap Gss Invt Corp Ord Cl A
Karbon Cap Partners Corp Unit 12/11/2030 (KBONU)

View all positions for Decagon Asset Management

Top funds holding Cidara Therapeutics

RA Capital Management
Vanguard Group
BlackRock
BVF
UBS Group
Darwin Global Management
Vivo Capital
State Street Corporation
Susquehanna International
FMR
Leucadia National Corporation
Paradigm Biocapital Advisors
Citadel Advisors
Henderson Group
Glazer Capital

View all funds holding Cidara Therapeutics